NCT02424682View on ClinicalTrials.gov

Safety of Herceptin/Trastuzumab in Metastatic Breast Cancer

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Breast Cancer, Metastatic Breast Cancer
Interventions
OTHER

No intervention

No intervention administered in this study

Trial Locations (1)

21204

Kamenitz

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02424682 - Safety of Herceptin/Trastuzumab in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter